ARCHIVES

Phase III Alimta Trial Fails To Extend Progression-Free Survival Without Grade 4 Adverse Events

This article is from The Cancer Letter archive.

Vol. 36 No. 6 | June 28, 2013

Download PDF Visit The Full Archive

Related Articles

“Sloppy” Searle Studies Described By FDA At Kennedy Hearing; Rauscher “Outraged”

January 23, 1976

Cancer Centers Win Majority Of Grants In Recent NCI RFAs, Klausner Tells AACI.

October 6, 2000

Chemical, Viral Carcinogenesis Should Not Be Separated: Shimkin

July 14, 1978

UICC Seeks Nominations for Mucio Athayde Prize.

January 7, 2000

NCI Advisors Set SPORE Review Criteria, Approve Plan To Fund New Ovarian Grant

June 26, 1998

Fish Oil May Help Prevent Weight Loss In Cancer Patients

September 26, 2003